1,2-Dimethyl-3-(1-methylethenyl)cyclopentyl acetate
Common Name: |
1,2-Dimethyl-3-(1-methylethenyl)cyclopentyl acetate |
IUPAC Name: |
[(1S,2R,3R)-1,2-dimethyl-3-prop-1-en-2-ylcyclopentyl] acetate |
Molecular Formula: |
C10H14O2 |
SMILES: |
CC1C(CCC1(C)OC(=O)C)C(=C)C |
Inchi: |
1S/C12H20O2/c1-8(2)11-6-7-12(5,9(11)3)14-10(4)13/h9,11H,1,6-7H2,2-5H3/t9-,11+,12+/m1/s1 |
Inchi Key: |
NKWCOKZUKIEZAR-USWWRNFRSA-N |
Cas No: |
94346-09-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
166.22 |
Mass (g/mol) |
196.146 |
Molar Refractivity |
48.60 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
219.00 to 223.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.81 |
Vapor Density (Air =1) |
6.8 |
Fraction Csp3 |
0.40 |
LogP |
2.93 |
iLOGP |
2.52 |
XLOGP3 |
2.09 |
WLOGP |
2.02 |
MLOGP |
1.83 |
ESOL Log S |
-2.29 |
ESOL Solubility (mg/ml) |
0.846 |
ESOL Solubility (mol/l) |
0.005 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.11 |
Ali Solubility (mg/ml) |
1.3 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.45 |
Silicos-IT Solubility (mg/ml) |
0.06 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.83 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.719 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |